Tamam El-Elimat

Affiliations: 
Chemistry & Biochemistry UNC Greensboro, Greensboro, NC, United States 
Google:
"Tamam El-Elimat"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharie AHA, Jadallah RK, Al-Bataineh MZ, et al. (2025) Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors. Cancer Control : Journal of the Moffitt Cancer Center. 32: 10732748251325587
Kuttikrishnan S, Ansari AW, Suleman M, et al. (2024) The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition. Cell Proliferation. e13773
Al Sharie AH, Al Masoud EB, Jadallah RK, et al. (2024) Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma. Medicine. 103: e39678
Khan A, Waheed Y, Kuttikrishnan S, et al. (2024) Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer. Frontiers in Pharmacology. 15: 1352907
Kuttikrishnan S, Hasan M, Prabhu KS, et al. (2024) Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model. Experimental Cell Research. 435: 113907
Pourhadi H, El-Elimat T, Rangel-Grimaldo M, et al. (2023) Semisynthesis, Characterization, and Biological Evaluation of Fluorinated Analogues of the Spirobisnaphthalene, Diepoxin-η. Tetrahedron Letters. 134
Kuttikrishnan S, Ahmad F, Mateo JM, et al. (2023) Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT/SKP2 signaling pathway. Cell Biology International
Kuttikrishnan S, Masoodi T, Ahmad F, et al. (2023) In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway. Journal of Dermatological Science
Al Sharie AH, Abu Zahra AM, El-Elimat T, et al. (2023) Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. Medicine. 102: e35004
Al Sharie AH, Al Zu'bi YO, El-Elimat T, et al. (2023) Expression Is a Potential Prognostic Biomarker in Non-Metastasized Clear Cell Renal Cell Carcinoma. Journal of Personalized Medicine. 13
See more...